CN104187681B - A kind of reducing blood sugar and blood fat health food and preparation method thereof - Google Patents
A kind of reducing blood sugar and blood fat health food and preparation method thereof Download PDFInfo
- Publication number
- CN104187681B CN104187681B CN201410478194.6A CN201410478194A CN104187681B CN 104187681 B CN104187681 B CN 104187681B CN 201410478194 A CN201410478194 A CN 201410478194A CN 104187681 B CN104187681 B CN 104187681B
- Authority
- CN
- China
- Prior art keywords
- powder
- blood sugar
- radix puerariae
- parts
- fructus momordicae
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 210000004369 blood Anatomy 0.000 title claims abstract description 84
- 239000008280 blood Substances 0.000 title claims abstract description 84
- 235000013402 health food Nutrition 0.000 title claims abstract description 27
- 238000002360 preparation method Methods 0.000 title claims abstract description 21
- 239000000843 powder Substances 0.000 claims abstract description 96
- 241000219780 Pueraria Species 0.000 claims abstract description 21
- 241000222336 Ganoderma Species 0.000 claims abstract description 17
- 241001076416 Dendrobium tosaense Species 0.000 claims abstract description 13
- 239000002994 raw material Substances 0.000 claims abstract description 5
- 239000002775 capsule Substances 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 7
- 238000004108 freeze drying Methods 0.000 claims description 5
- 239000011812 mixed powder Substances 0.000 claims 3
- 230000001954 sterilising effect Effects 0.000 claims 1
- 238000004659 sterilization and disinfection Methods 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 10
- 230000036541 health Effects 0.000 abstract description 7
- 150000002632 lipids Chemical class 0.000 abstract description 7
- 208000031226 Hyperlipidaemia Diseases 0.000 abstract description 5
- 230000002265 prevention Effects 0.000 abstract description 3
- 210000000748 cardiovascular system Anatomy 0.000 abstract description 2
- 230000001737 promoting effect Effects 0.000 abstract 1
- 108010007622 LDL Lipoproteins Proteins 0.000 description 22
- 102000007330 LDL Lipoproteins Human genes 0.000 description 22
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 17
- 235000013305 food Nutrition 0.000 description 14
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 13
- 239000008103 glucose Substances 0.000 description 13
- 239000003814 drug Substances 0.000 description 11
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 9
- 235000001014 amino acid Nutrition 0.000 description 6
- 150000001413 amino acids Chemical class 0.000 description 6
- 229940079593 drug Drugs 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 241000196324 Embryophyta Species 0.000 description 5
- 235000012000 cholesterol Nutrition 0.000 description 5
- 201000001421 hyperglycemia Diseases 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 150000003626 triacylglycerols Chemical class 0.000 description 5
- 150000004676 glycans Chemical class 0.000 description 4
- 230000036039 immunity Effects 0.000 description 4
- 229920001282 polysaccharide Polymers 0.000 description 4
- 239000005017 polysaccharide Substances 0.000 description 4
- 238000010298 pulverizing process Methods 0.000 description 4
- 210000002966 serum Anatomy 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 206010020772 Hypertension Diseases 0.000 description 3
- 108010028554 LDL Cholesterol Proteins 0.000 description 3
- 229930013930 alkaloid Natural products 0.000 description 3
- 150000003797 alkaloid derivatives Chemical class 0.000 description 3
- 230000003064 anti-oxidating effect Effects 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- 238000001647 drug administration Methods 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Natural products OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 240000000759 Lepidium meyenii Species 0.000 description 2
- 235000000421 Lepidium meyenii Nutrition 0.000 description 2
- 244000302512 Momordica charantia Species 0.000 description 2
- 235000009811 Momordica charantia Nutrition 0.000 description 2
- 102000016943 Muramidase Human genes 0.000 description 2
- 108010014251 Muramidase Proteins 0.000 description 2
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 2
- 206010067482 No adverse event Diseases 0.000 description 2
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 2
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 229930003944 flavone Natural products 0.000 description 2
- -1 flavone compound Chemical class 0.000 description 2
- 235000011949 flavones Nutrition 0.000 description 2
- 230000002538 fungal effect Effects 0.000 description 2
- 210000000232 gallbladder Anatomy 0.000 description 2
- 235000008216 herbs Nutrition 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 235000010335 lysozyme Nutrition 0.000 description 2
- 239000004325 lysozyme Substances 0.000 description 2
- 229960000274 lysozyme Drugs 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 229920001184 polypeptide Polymers 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 230000003014 reinforcing effect Effects 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- 230000035807 sensation Effects 0.000 description 2
- 235000019615 sensations Nutrition 0.000 description 2
- 229930193551 sterin Natural products 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 1
- RQOCXCFLRBRBCS-UHFFFAOYSA-N (22E)-cholesta-5,7,22-trien-3beta-ol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CCC(C)C)CCC33)C)C3=CC=C21 RQOCXCFLRBRBCS-UHFFFAOYSA-N 0.000 description 1
- QWUWMCYKGHVNAV-UHFFFAOYSA-N 1,2-dihydrostilbene Chemical group C=1C=CC=CC=1CCC1=CC=CC=C1 QWUWMCYKGHVNAV-UHFFFAOYSA-N 0.000 description 1
- GTBXZWADMKOZQJ-UHFFFAOYSA-N 1-phenanthrol Chemical compound C1=CC2=CC=CC=C2C2=C1C(O)=CC=C2 GTBXZWADMKOZQJ-UHFFFAOYSA-N 0.000 description 1
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 241000554155 Andes Species 0.000 description 1
- 208000037260 Atherosclerotic Plaque Diseases 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 241000219193 Brassicaceae Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 241001523681 Dendrobium Species 0.000 description 1
- 241000026010 Dendrobium candidum Species 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- DNVPQKQSNYMLRS-NXVQYWJNSA-N Ergosterol Natural products CC(C)[C@@H](C)C=C[C@H](C)[C@H]1CC[C@H]2C3=CC=C4C[C@@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C DNVPQKQSNYMLRS-NXVQYWJNSA-N 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 240000008397 Ganoderma lucidum Species 0.000 description 1
- 235000001637 Ganoderma lucidum Nutrition 0.000 description 1
- 108010023302 HDL Cholesterol Proteins 0.000 description 1
- 108010010234 HDL Lipoproteins Proteins 0.000 description 1
- 102000015779 HDL Lipoproteins Human genes 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- 206010024229 Leprosy Diseases 0.000 description 1
- 102000004895 Lipoproteins Human genes 0.000 description 1
- 108090001030 Lipoproteins Proteins 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 244000183278 Nephelium litchi Species 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- RXUWDKBZZLIASQ-UHFFFAOYSA-N Puerarin Natural products OCC1OC(Oc2c(O)cc(O)c3C(=O)C(=COc23)c4ccc(O)cc4)C(O)C(O)C1O RXUWDKBZZLIASQ-UHFFFAOYSA-N 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 235000004443 Ricinus communis Nutrition 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 206010043458 Thirst Diseases 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- 206010047531 Visual acuity reduced Diseases 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 235000009392 Vitis Nutrition 0.000 description 1
- 241000219095 Vitis Species 0.000 description 1
- 208000005946 Xerostomia Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- ZFLXCZJBYSPSKU-CRHREIPCSA-N [(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] (e,1e)-5-methylsulfinyl-n-sulfooxypent-4-enimidothioate Chemical compound CS(=O)\C=C\CC\C(=N/OS(O)(=O)=O)S[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O ZFLXCZJBYSPSKU-CRHREIPCSA-N 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- ZOJBYZNEUISWFT-UHFFFAOYSA-N allyl isothiocyanate Chemical compound C=CCN=C=S ZOJBYZNEUISWFT-UHFFFAOYSA-N 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N benzo-alpha-pyrone Natural products C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000019636 bitter flavor Nutrition 0.000 description 1
- 230000000157 blood function Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 235000001671 coumarin Nutrition 0.000 description 1
- 229930182483 coumarin glycoside Natural products 0.000 description 1
- 150000008140 coumarin glycosides Chemical class 0.000 description 1
- 150000004775 coumarins Chemical class 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 235000018927 edible plant Nutrition 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- DNVPQKQSNYMLRS-SOWFXMKYSA-N ergosterol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H](CC[C@]3([C@H]([C@H](C)/C=C/[C@@H](C)C(C)C)CC[C@H]33)C)C3=CC=C21 DNVPQKQSNYMLRS-SOWFXMKYSA-N 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 201000005577 familial hyperlipidemia Diseases 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- ZFLXCZJBYSPSKU-YYSSDTNZSA-N glucoraphenin Natural products C[S@](=O)C=CCCC(=NOS(=O)(=O)O)S[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O ZFLXCZJBYSPSKU-YYSSDTNZSA-N 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000003345 hyperglycaemic effect Effects 0.000 description 1
- 230000003516 hyperlipidaemic effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 235000012902 lepidium meyenii Nutrition 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000008164 mustard oil Substances 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- HKEAFJYKMMKDOR-VPRICQMDSA-N puerarin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=CC(C2=O)=C1OC=C2C1=CC=C(O)C=C1 HKEAFJYKMMKDOR-VPRICQMDSA-N 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 230000036299 sexual function Effects 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 235000020795 whole food diet Nutrition 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/01—Instant products; Powders; Flakes; Granules
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/10—Products from fruits or vegetables; Preparation or treatment thereof of tuberous or like starch containing root crops
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L31/00—Edible extracts or preparations of fungi; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/074—Ganoderma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
- A61K36/8984—Dendrobium
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Animal Behavior & Ethology (AREA)
- Alternative & Traditional Medicine (AREA)
- Veterinary Medicine (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
The present invention relates to health food of a kind of reducing blood sugar and blood fat and preparation method thereof, it is made up of following raw material by weight: pueraria root powder 50 60 parts, powder of Radix Puerariae 15 25 parts, Ganoderma powder 4 10 parts, dendrobium officinale powder 6 12 parts, Fructus Momordicae charantiae powder 5 12 parts, prove through human experiment experiment, there is the health care of reducing blood sugar and blood lipid, the present invention is formed and effect of lowering blood sugar by number of ways prevention hyperlipidemia, to promoting that cardiovascular system health plays good health-care effect, without any untoward reaction.
Description
Technical field
The present invention relates to field of health care food, be specifically related to health food of a kind of reducing blood sugar and blood fat and preparation method thereof.
Background technology
Lepidinm meyenii Walp (English name " maca ", latin name " Lepidium meyenii Walp. ") is a kind of original South America
The Cruciferae separate row Vegetable spp that Peru's Andes height above sea level is more than 3500 meters is annual or 2 years raw medicinal and edible plants.
Lepidinm meyenii Walp has long plantation and edible history, records according to history records, was just tamed plantation in original producton location before more than 2000 year,
Lepidinm meyenii Walp is not only nutritious food, is also the medicinal herbs with multiple magical effect, according to modern scientific research, agate
Coffee has multiple nutritional components, and such as protein, aminoacid, polysaccharide, multivitamin etc., Lepidinm meyenii Walp is possibly together with tool in addition
There are the natural plant active component mustard oil of special efficacy, alkaloid, aminoacid, Lepidinm meyenii Walp alkene, macamide and ore deposit
Material trace element, has raising immunity, improves sexual function, endocrine regulation, resisting fatigue, antioxidation, anti-
The pharmacological effects such as tumor, clinically can be used for improve and therapeutic function, improve climacteric syndrome, treat lean
Blood, physical strength reinforcing, blood fat reducing etc..
Radix Puerariae is a kind of integration of edible and medicinal herbs food, and its main component is starch, flavone compound, puerarin, has recklessly
Glucoraphenin, aminoacid, Coumarins etc..Having a resolving heat and reducing pathogenic fire, YIN nourishing is detoxified, and yang invigorating promotes the production of body fluid, stimulating appetite it
Effect, to treat and prevent septum pectorale dysphoria with smothery sensation, middle wind headache, hypertension, coronary heart disease, blood fat reducing, anticancer, fat-reducing,
Anti-ageing waiting for a long time all has special efficacy.Meanwhile, in modern scientific research, powder of Radix Puerariae also have needed by human zinc,
Element and the aminoacid such as ferrum, calcium, vitamin B1, B2, be the wholefood that nutritive value is the highest.
Ganoderma (formal name used at school: Ganoderma Lucidum Karst) is the sporophore of porous castor section fungus Ganoderma, property
Temperature, lightly seasoned, gas is special, and mildly bitter flavor is puckery, main containing aminoacid, polypeptide, protein, fungal lysozyme (fungal
Lysozyme), and saccharide (reducing sugar and polysaccharide), ergosterol, triterpenes, coumarin glycoside, volatile oil,
Stearic acid, benzoic acid, alkaloid, vitamin B2 and C etc.；Spore is also containing mannitol, trehalose.Efficacy effect:
Protecting liver and detoxication, treat diabetes, improve cardiovascular system, reduce cholesterolemia, lipoprotein and triglyceride, and
Can the formation of prevention of arterial atherosclerotic plaque, vessel softening, prevention platelet aggregation etc. act on.
Herba Dendrobii (Dendrobium candidum Wall.ex Lindl) is the perennial draft of growing nonparasitically upon another plant of the orchid family Dendrobium
Plant, is a kind of health food, and it is containing abundant polysaccharide, bibenzyl and phenanthrol constituents, alkaloid, multiple people
Trace element that body is required and aminoacid etc., be a kind of rare Chinese medicine, have the stomach reinforcing that promotes the production of body fluid, nourishing YIN and clearing away heat, lung moistening
Cough-relieving, the improving eyesight that wets one's whistle, life lengthening, enhancing immunity, antitumor, antioxidation, blood sugar lowering, anti-Bai Neilong
Effect, is mainly used in cloudy impairment of body fluid and loses, and xerostomia is irritated, and lack of appetite is retched, deficiency-heat and poor vision after being ill.
Fructus Momordicae charantiae (Momordica charantia) has another name called brocade Fructus Litchi, leprosy Fructus Vitis viniferae etc., a kind of medicine food dual purpose plant, and it is rich
Containing various active compositions such as bitter melon polysaccharide, saponin, polypeptide, flavone compounds, have auxiliary hyperglycemic, blood fat reducing,
The health cares such as antioxidation, enhancing immunity and pre-preventing obesity.
According to statistics, if current blood sugar lowering, the drug main western medicine of blood fat reducing and Chinese medicine, but price is held high
Expensive, toxic and side effects in various degree, drug withdrawal easily rebounds, and does not reaches radical cure effect.Scientific research now: the deficiency of vital energy,
The deficiency of YIN is scorching and inflammation is hyperglycemia and the main pathogenesis of hyperlipidemia primary disease, because of present invention Lepidinm meyenii Walp, Radix Puerariae, Fructus Momordicae charantiae,
Ganoderma, the mutual compatibility of Herba Dendrobii make QI invigorating, YIN nourishing, heat clearing away, the health food that has no side effect to drop blood
Sugar and blood fat.The present invention has safely, effectively, conveniently, inexpensive medicative diet for food therapy hyperglycemia hyperlipidemia.
Summary of the invention
It is an object of the invention to provide a kind of convenient and swift, in good taste, there is certain medicated diet reducing blood sugar and blood fat
Health food and preparation method thereof.Utilize the product that the present invention produces, be fully retained Lepidinm meyenii Walp, Radix Puerariae, Ganoderma,
Herba Dendrobii and the natural nutrition composition of Fructus Momordicae charantiae.Produce one by biological food engineering brewing technique and sky is fully retained
So nutrient ingredient of food is constant, not only facilitates but also be suitable for a kind of health-care nutritional food that hyperglycemia people with hyperlipidemia is edible.
This product can meet the market demand, caters to again all kinds of consumer group and thirsts for, is also chinese tradition cuisines and modern food
The innovation that science and technology combines.
The present invention is achieved by following technical solution: a kind of reducing blood sugar and blood fat health food, by weight
It is made up of following raw material: pueraria root powder 50-60 part, powder of Radix Puerariae 15-25 part, Ganoderma powder 4-10 part, dendrobium officinale powder
6-12 part, Fructus Momordicae charantiae powder 5-12 part.Tablet, capsule or powder etc. can be made.
The present invention is made by the steps:
First pueraria root powder, powder of Radix Puerariae are prepared: it is 8% that the Lepidinm meyenii Walp cleaned up and Radix Puerariae are dried to moisture, then warp
Cross super micron mill and be crushed to 400 mesh, weigh gained pueraria root powder 50 60 parts, powder of Radix Puerariae 15 25 parts the most respectively；
Next prepares wall-breaking lucidum powder: weighs quality by proportioning and reaches the Ganoderma of requirement through high energy nanometer impact pulverizing
It is broken to 300nm, weighs 4 10 parts of wall-breaking lucidum powder；
Then the preparation of Herba Dendrobii, Fructus Momordicae charantiae: Herba Dendrobii and Fructus Momordicae charantiae are through lyophilization, then through micronizing
Machine is crushed to 400 mesh, weighs gained dendrobium officinale powder 6 12 parts, Fructus Momordicae charantiae powder 5 12 parts the most respectively；
Finally, by the described pueraria root powder prepared by proportioning, powder of Radix Puerariae, wall-breaking lucidum powder, dendrobium officinale powder, Fructus Momordicae charantiae powder
Mix homogeneously, dresses up capsule through dry powder sheeting machine tabletting or capsule machine, sterilizes, checks, packs to obtain described fall blood
Sugar blood fat reducing healthcare food.
The health food of a kind of reducing blood sugar and blood lipid that the present invention provides, with Lepidinm meyenii Walp, Radix Puerariae, wall-breaking lucidum, Herba Dendrobii,
Fructus Momordicae charantiae is that natural health care made by raw material, and the composition between its each raw material has and cooperates potentiation, keeps
The balanced proportions of each material, is the basis maintaining health.The preparation of the health food of the reducing blood sugar and blood lipid that the present invention provides
What method efficiency was good, complete retains Lepidinm meyenii Walp, Radix Puerariae, Ganoderma, Herba Dendrobii and the effective ingredient of Fructus Momordicae charantiae, and technique is simple,
Good product quality.Natural Lepidinm meyenii Walp, Radix Puerariae, Ganoderma, Herba Dendrobii, Fructus Momordicae charantiae medicinal health-care food by with human body in tie
Conjunction carries out metabolism, thus reduces blood fat, reduces blood glucose, defying age, enhancing immunity.The applicant is real through the several years
Trample application attestation contain the present invention provide natural medicinal health-care food safe and effective.
Detailed description of the invention
Below in conjunction with detailed description of the invention, the present invention will be further described, it should be pointed out that set forth below
Illustrative embodiments, is not meant to limit the present invention, and those skilled in the art is disclosed in this invention
In extent and scope, some that can make simply are replaced, and are the most all scope of the invention.
Embodiment 1
Present embodiment is the health food of a kind of reducing blood sugar and blood fat, and it is by the crude drug of following weight portion
It is prepared from:
Pueraria root powder 50 parts, powder of Radix Puerariae 25 parts, Ganoderma powder 10 parts, Herba Dendrobii 10 parts, 5 parts of Fructus Momordicae charantiae.
Its preparation method comprises the following steps:
First pueraria root powder, powder of Radix Puerariae are prepared: it is 8% that the Lepidinm meyenii Walp cleaned up and Radix Puerariae are dried to moisture, then warp
Cross super micron mill and be crushed to 400 mesh, weigh gained pueraria root powder 50 parts the most respectively and powder of Radix Puerariae 25 parts is standby；
Next prepares wall-breaking lucidum powder: weighs quality by proportioning and reaches the Ganoderma of requirement through high energy nanometer impact pulverizing
It is broken to 300nm, weighs 10 parts of wall-breaking lucidum powder standby；
Then the preparation of dendrobium officinale powder, Fructus Momordicae charantiae powder: Herba Dendrobii and Fructus Momordicae charantiae are through lyophilization, then through ultra micro
Pulverizer is crushed to 400 mesh, weighs gained dendrobium officinale powder 10 parts the most respectively and Fructus Momordicae charantiae powder 5 parts is standby；
Finally, by the described pueraria root powder prepared by proportioning, powder of Radix Puerariae, wall-breaking lucidum powder, dendrobium officinale powder, Fructus Momordicae charantiae powder
Mix homogeneously, dresses up capsule through capsule machine, sterilizes, checks, packs to obtain described reducing blood sugar and blood fat health food,
Both.
Embodiment 2
Present embodiment is a kind of reducing blood sugar and blood fat health food, and it is by the crude drug system of following weight portion
For forming:
Pueraria root powder 60 parts, powder of Radix Puerariae 20 parts, Ganoderma powder 4 parts, Herba Dendrobii 6 parts, 10 parts of Fructus Momordicae charantiae.
Its preparation method comprises the following steps:
First pueraria root powder, powder of Radix Puerariae are prepared: it is 8% that the Lepidinm meyenii Walp cleaned up and Radix Puerariae are dried to moisture, then warp
Cross super micron mill and be crushed to 400 mesh, weigh gained pueraria root powder 60 parts the most respectively and powder of Radix Puerariae 20 parts is standby；
Next prepares wall-breaking lucidum powder: weighs quality by proportioning and reaches the Ganoderma of requirement through high energy nanometer impact pulverizing
It is broken to 300nm, weighs 4 parts of wall-breaking lucidum powder standby；
Then the preparation of Herba Dendrobii, Fructus Momordicae charantiae: Herba Dendrobii and Fructus Momordicae charantiae are through lyophilization, then through micronizing
Machine is crushed to 400 mesh, weighs gained Herba Dendrobii 6 parts the most respectively and 10 parts of Fructus Momordicae charantiae is standby；
Finally, by the described pueraria root powder prepared by proportioning, powder of Radix Puerariae, wall-breaking lucidum powder, dendrobium officinale powder, Fructus Momordicae charantiae powder
Mix homogeneously, through dry powder sheeting machine tabletting, sterilizes, checks, packs to obtain described reducing blood sugar and blood fat health food,
Both.
Embodiment 3
Present embodiment is a kind of reducing blood sugar and blood fat health food, and it is by the crude drug system of following weight portion
For forming:
Pueraria root powder 55 parts, powder of Radix Puerariae 15 parts, Ganoderma powder 6 parts, Herba Dendrobii 12 parts, 12 parts of Fructus Momordicae charantiae.
Its preparation method comprises the following steps:
First pueraria root powder, powder of Radix Puerariae are prepared: it is 8% that the Lepidinm meyenii Walp cleaned up and Radix Puerariae are dried to moisture, then warp
Cross super micron mill and be crushed to 400 mesh, weigh gained pueraria root powder 55 parts the most respectively and powder of Radix Puerariae 15 parts is standby；
Next prepares wall-breaking lucidum powder: weighs quality by proportioning and reaches the Ganoderma of requirement through high energy nanometer impact pulverizing
It is broken to 300nm, weighs 6 parts of wall-breaking lucidum powder standby；
Then the preparation of Herba Dendrobii, Fructus Momordicae charantiae: Herba Dendrobii and Fructus Momordicae charantiae are through lyophilization, then through micronizing
Machine is crushed to 400 mesh, weighs gained Herba Dendrobii 12 parts the most respectively and 12 parts of Fructus Momordicae charantiae is standby；
Finally, by the described pueraria root powder prepared by proportioning, powder of Radix Puerariae, wall-breaking lucidum powder, dendrobium officinale powder, Fructus Momordicae charantiae powder
It is mixed into powder, sterilizes, check, pack to obtain described reducing blood sugar and blood fat health food, both.
Test example 1
Plant selected by the present invention is all food, and in November, 2013, in May, 2014, chooses 200 examples altogether,
Hyperglycemia hyperlipemic patients is treatment target, the maleest 100 people, female 100 people, average 58.5 years old, at random
It is divided into A, B two groups, often organizes each 100 people.A group takes the reducing blood sugar and blood lipid capsule that certain company produces, as comparison
Group；B group is taken embodiment 1 production and is obtained reducing blood sugar and blood lipid health food, as test group；
Instructions of taking, observational technique, curative effect judgment criteria are as follows:
1, instructions of taking
A group take certain company produce reducing blood sugar and blood lipid capsule (specification 0.3g/ grain), 2 times/day, each 2,
As a control group；B group is taken the present embodiment 1 and is produced the reducing blood sugar and blood lipid health food (specification 0.25g/ grain) obtained,
2 times/day, each 4.As test group.Two groups all take every 40 days be a course for the treatment of, all patients take
2 courses for the treatment of of medicine.
2, observational technique
Have a blood test respectively before and after taking pressure, blood fat, urine, stool routine examination and occult blood, Liver and kidney function.Take 10 days periods to observe
Once, situation, untoward reaction are improved including symptom, sign.
3, efficacy assessment standard
Before drug administration 1 day, drug administration after the 40th day and after drug administration the 80th day, to often organizing respectively
Detection blood glucose (Glu), serum triglycerides (TG), cholesterol (CHOL), low density lipoprotein, LDL (LDL-C),
High density lipoprotein (HDL-C) index；
All index mean ± standard deviations represent, result is analyzed by the statistical method of application t inspection, P ＜ 0.05
Think tool significance.
4. therapeutic outcome: every improvement situation and the results are shown in Table 1
The comparison of Glu, TG, CHOL, LDL-C before and after 1 liang of table group patient on medication
Before annotation: C represents and takes；D represents and takes latter 40 days；E represents and takes latter 80 days.
From above table it can be seen that the present invention to reduce fasting glucose (Glu), serum triglycerides (TG),
Cholesterol (CHOL), low density lipoprotein, LDL (LDL-C) have positive effect.
Beneficial effects of the present invention is expanded on further below by clinical trial, takes what above-described embodiment 1-3 prepared
Health food is tested as follows.
Case 1
Xue, man, 39 years old, over nearly 1 year, blood fat and body weight were gradually increased.The previous day taking this test products arrives
Examination in hospital is diagnosed as, hyperglycemia, hyperlipemia with mild fatty liver: fasting glucose 12.7mmol/L serum
Cholesterol 9.3mmol/L, triglyceride is 6.2mmol/L, and low density lipoprotein, LDL is 7.6mmol/L, and has height
Blood pressure.Take 4 weeks check fasting glucose of reducing blood sugar and blood fat health food of the embodiment of the present invention 1 preparation
5.6mmol/L, serum cholesterol is 7.2mmol/L, and triglyceride is 4.4mmol/L, and low density lipoprotein, LDL is
6.6mmol/L, checked after 3 months, and fasting glucose 5.0mmol/L, triglyceride is 1.56mmol/L, serum gallbladder
Sterin is 4.45mmol/L, and low density lipoprotein, LDL is 4.12mmol/L, is all reduced to normal range, so far blood glucose,
Blood fat all maintains a good state, and take period find test group patient have no adverse reaction.
Case 2
Wood certain, female, 34 years old, puerperal, body weight was continuously increased over one year.Take the fall of the embodiment of the present invention 2 preparation
Fasting glucose 10.1mmol/L before blood glucose blood fat reducing healthcare food, serum cholesterol 8.6mmol/L, triglyceride is
7.0mmol/L, low density lipoprotein, LDL is 7.4mmol/L, and has hypertension.Take the embodiment of the present invention 2 preparation
4 weeks check fasting glucose 5.0mmol/L of reducing blood sugar and blood fat health food, serum cholesterol is 7.2mmol/L, glycerol
Three fat are 4.4mmol/L, and low density lipoprotein, LDL is 6.0mmol/L, check, fasting glucose 4.8mmol/L after 3 months,
Triglyceride is 1.54mmol/L, and serum cholesterol is 4.42mmol/L, and low density lipoprotein, LDL is
4.12mmol/L, is all reduced to normal range, and blood glucose, blood fat all maintain a good state so far, and takes period discovery
Test group patient have no adverse reaction.
Case 3
And certain, man, 44 years old, before taking the reducing blood sugar and blood fat health product of the embodiment of the present invention 3 preparation, fasting blood
Sugar 9.8mmol/L, serum cholesterol 8.42mmol/L, triglyceride is 10.15mmol/L, and low density lipoprotein, LDL is
8.0mmol/L, takes reducing blood sugar and blood fat health food 2 months weeks check fasting blood of the embodiment of the present invention 3 preparation
Sugar 5.4mmol/L, serum cholesterol is 5.42mmol/L, and triglyceride is 3.9mmol/L, and low density lipoprotein, LDL is
5.4mmol/L, checked after 4 months, and fasting glucose 4.7mmol/L, triglyceride is 2.44mmol/L, serum gallbladder
Sterin is 4.52mmol/L, and low density lipoprotein, LDL is 4.36mmol/L, is all reduced to normal range, and the most unobstructed
And soft, facial acne and frequent anaphylaxis are scratched where it itches and are reduced the most simultaneously and eliminate, and interior-heat fires situation and is obviously improved.
Case 4
And certain, female 60 years old, suffers from cardiovascular and cerebrovascular disease, hyperlipidemia 12 years, has hypertension simultaneously.Once took multiple
Medicine, effect is the most undesirable.After selecting the reducing blood sugar and blood fat health food of the embodiment of the present invention 4 preparation later,
After examination took for 4 week, sensation the numbest original right arm is the numbest, and chest is not ached, and blood fat is also
Significantly reducing, by consolidating course for the treatment of of 3 months, blood fat recovers normal completely, and drug withdrawal was not the most recurred.
Claims (2)
1. a reducing blood sugar and blood fat health food, it is characterised in that be made up of following raw material by weight: pueraria root powder 50-60 part, powder of Radix Puerariae 15-25 part, Ganoderma powder 4-10 part, dendrobium officinale powder 6-12 part and Fructus Momordicae charantiae powder 5-12 part, preparation process is as follows:
(1) prepare pueraria root powder, powder of Radix Puerariae: it is 8% that the Lepidinm meyenii Walp cleaned up and Radix Puerariae are dried to moisture, then is crushed to 400 mesh through super micron mill, weigh gained pueraria root powder 50-60 part and powder of Radix Puerariae 15-25 part the most respectively；
(2) prepare wall-breaking lucidum powder: Ganoderma is crushed to 300nm through high energy nanometer impact grinding, weigh wall-breaking lucidum powder 4-10 part；
(3) preparation of dendrobium officinale powder, Fructus Momordicae charantiae powder: Herba Dendrobii and Fructus Momordicae charantiae are through lyophilization, then are crushed to 400 mesh through super micron mill, weighs gained dendrobium officinale powder 6-12 part and Fructus Momordicae charantiae powder 5-12 part the most respectively；
(4) mixed powder will be obtained by above-mentioned prepared pueraria root powder, powder of Radix Puerariae, wall-breaking lucidum powder, dendrobium officinale powder and Fructus Momordicae charantiae powder mix homogeneously, through sterilization, check and be packaged to be described reducing blood sugar and blood fat health food.
A kind of reducing blood sugar and blood fat health food the most according to claim 1, it is characterised in that tablet that described reducing blood sugar and blood fat health food is powder or mixed powder to be pressed into through dry powder sheeting machine or the capsule that mixed powder is dressed up through capsule machine.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410478194.6A CN104187681B (en) | 2014-09-18 | 2014-09-18 | A kind of reducing blood sugar and blood fat health food and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410478194.6A CN104187681B (en) | 2014-09-18 | 2014-09-18 | A kind of reducing blood sugar and blood fat health food and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN104187681A CN104187681A (en) | 2014-12-10 |
| CN104187681B true CN104187681B (en) | 2016-08-24 |
Family
ID=52073196
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410478194.6A Expired - Fee Related CN104187681B (en) | 2014-09-18 | 2014-09-18 | A kind of reducing blood sugar and blood fat health food and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104187681B (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105011286A (en) * | 2015-08-14 | 2015-11-04 | 谢晓亮 | Balsam pear maca functional drink |
| CN105124445A (en) * | 2015-09-28 | 2015-12-09 | 陈薇 | Detoxifying and fire purging natto powder and preparing method |
| CN107970367A (en) * | 2017-12-13 | 2018-05-01 | 国珍健康科技（北京）有限公司 | A kind of Maca composite for improving glucose -lipid metabolism disorder |
| CN109287986A (en) * | 2018-08-09 | 2019-02-01 | 珠海经济特区天然药物研究所有限公司 | A kind of dendrobium nobile composition and preparation method thereof with lower hyperlipidemia, hypertension, hyperglycemia function |
| CN112790378A (en) * | 2021-02-01 | 2021-05-14 | 陈礼平 | Edible fungus functional food with effect of reducing hypertension, hyperglycemia and hyperlipidemia |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1154255A (en) * | 1996-01-11 | 1997-07-16 | 严跃华 | Capsulized traditional Chinese proprietary medicine- |
| BRPI0901392A2 (en) * | 2009-04-07 | 2011-01-04 | Masaaki Tanisue Walter | chemical composition of food supplement / antioxidant remedy |
| CN102318823A (en) * | 2011-10-07 | 2012-01-18 | 刘和勇 | Dendrobium nobile nutritive powder |
| CN102552527A (en) * | 2012-02-02 | 2012-07-11 | 峨眉山天梁星制药有限公司 | Traditional Chinese medicine composition used for treating diabetic complications and reducing blood sugar |
| CN102757880A (en) * | 2012-07-25 | 2012-10-31 | 北京中科健宇生物科技有限公司 | Maca health-care wine and preparation method thereof |
| CN103584098A (en) * | 2013-11-16 | 2014-02-19 | 丽江玛咖生物科技有限公司 | Maca almond tablet and preparation method thereof |
-
2014
- 2014-09-18 CN CN201410478194.6A patent/CN104187681B/en not_active Expired - Fee Related
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1154255A (en) * | 1996-01-11 | 1997-07-16 | 严跃华 | Capsulized traditional Chinese proprietary medicine- |
| BRPI0901392A2 (en) * | 2009-04-07 | 2011-01-04 | Masaaki Tanisue Walter | chemical composition of food supplement / antioxidant remedy |
| CN102318823A (en) * | 2011-10-07 | 2012-01-18 | 刘和勇 | Dendrobium nobile nutritive powder |
| CN102552527A (en) * | 2012-02-02 | 2012-07-11 | 峨眉山天梁星制药有限公司 | Traditional Chinese medicine composition used for treating diabetic complications and reducing blood sugar |
| CN102757880A (en) * | 2012-07-25 | 2012-10-31 | 北京中科健宇生物科技有限公司 | Maca health-care wine and preparation method thereof |
| CN103584098A (en) * | 2013-11-16 | 2014-02-19 | 丽江玛咖生物科技有限公司 | Maca almond tablet and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN104187681A (en) | 2014-12-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103099089B (en) | Health-care product for reducing blood sugar and blood pressure, relaxing bowels, losing weight, resisting fatigue and improving sexual function and production technology thereof | |
| CN104026446B (en) | A kind of it is suitable for nutritional meal replacement powder that hyperglycemia population takes and preparation method thereof | |
| CN102907604B (en) | Health-care product having effects of reducing blood sugar and pressure, losing weight, relaxing bowels, maintaining beauty and resisting fatigue and production process thereof | |
| CN104187681B (en) | A kind of reducing blood sugar and blood fat health food and preparation method thereof | |
| CN101248874B (en) | Highland barley composite nutrition powder and method of preparing the same | |
| WO2016173511A1 (en) | Compositions comprising cyclocarya paliurus extract and preparation method and uses thereof | |
| CN103734421B (en) | Liver-benefiting kidney-tonifying stomach-invigorating tea and preparation method thereof | |
| CN102293273A (en) | Health tea capable of adjusting blood pressure, blood sugar and blood fat and preventing thrombus and apoplexy | |
| CN103191332A (en) | Composition and health-care product with stomach-invigorating and digestion-promoting functions | |
| CN104621287B (en) | A kind of balsam pear peptide tea composition and preparation method thereof | |
| CN105532998A (en) | Health-care tea containing cordyceps militaris and preparation method thereof | |
| CN101664184A (en) | Healthcare product for reducing blood fat and preparation method thereof | |
| CN106722105A (en) | A kind of selenium-rich glasswort health nutritious noodle and its production technology | |
| CN107467497A (en) | A kind of five cereals food therapeutic composition with anti-adiposity health care function and preparation method thereof | |
| CN106266631A (en) | A kind of compositions containing Radix Puerariae and extraction element thereof and method | |
| CN103355619B (en) | Fructus phyllanthi and Radix Puerariae health food | |
| CN104799286B (en) | Composition for improving immunity and preparation method of composition | |
| CN108066384A (en) | A kind of Chinese medicine preparation with strengthen immunity and preparation method thereof | |
| CN106581166A (en) | Anti-fatigue food, health product or pharmaceutical composition | |
| CN106107978A (en) | A kind of unknown mallow health care oral liquid of blood pressure lowering | |
| CN102552562A (en) | Formula for health care medicine capable of enhancing immunity and delaying aging | |
| KR101512230B1 (en) | Arthritis Remedy Composition and manufacture method having immunity and the circulation of the blood improvement fuction | |
| CN104997018A (en) | Yew enzyme health-care product as well as preparation method and application thereof | |
| CN101720830B (en) | Biological polysaccharide medicinal tea beverage | |
| CN105101817A (en) | Edible composition, preparation method therefor, and food product comprising the composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20160824 Termination date: 20190918 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |